Obtained Registration Certificate for Medical Device of Veloderm® in China

2010.01.29

Obtained Renewal of Imported Drug License for Co-dergocrine Mesylate in China

2010.01.15

Obtained Renewal of Imported Drug License for Ferplex® Iron Proteinsuccinylate Oral Solution in China

2010.01.14

Distribution Agreement signed to market Lercanidipine tablets in Hong Kong and Macau

2009.12.31

JENNEREX AND LEE’S PHARMACEUTICALS ANNOUNCE PARTNERSHIP FOR JX-594 IN CHINA

2009.11.23

Phase I Clinical Study on Antiplatelet Thrombolysin injection

2009.11.06

Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku A Move To Accelerate Market Diversification in China

2009.03.02

Anhui Government Official Visited Zhaoke Pharmaceutical (Hefei) Co. Ltd.

2008.12.22

Lee's Pharmaceutical Establishes New R&D Centre at the Hong Kong Science Park To Bolster the Group's R&D Capabilities

2008.12.17

New Drug Approval for Eyprotor® (Protein-free Calf Blood Extract Eye-gel) in China

2008.05.13

LEE'S SIGNED COLLABORATION AGREEMENT WITH NOVELOS

2007.12.19

SIGMA-TAU STRENGTHENS ITS PARTICIPATION IN LEE'S PHARMACEUTICALS

2007.09.20

Exclusive Distribution Agreement Signed for Aloxi® injection in China

2007.08.09

Completed the Pharmacokinetic Study of HIBOR® (Bemiparin Sodium)

2007.06.25

Distribution Agreement Signed with Italfarmaco of Italy for Serestill® in China

2007.06.18

Important milestones achieved in Clinical Studies of Stent & Balloon Catheter

2007.06.15

New Indication Approved for Cervicitis for Yallaferon

2006.10.18

Marketing Approval for Slounase® (Hemocoagulase) in China

2006.09.22

Approval to initiate a Clinical Trial for Hibor

2006.06.23

Approval for Clinical Study on Antiplatelet Thrombolysin injection

2006.02.20

Distribution agreement signed to market Propiverine Hydrochloride

2006.02.20

New Product Launch in Hong Kong - HIBOR® (Bemiparin Sodium)

2005.12.20

Completion of the Study of Yallaferon® in Cervicitis Patients

2005.12.20

New Drug Approval for Hemocoagulase snake venom

2005.10.17

Distribution of HORUS®S Coronary Stent

2005.09.28

New Indication Approved for Yallaferon®

2005.09.07

Distribution Agreement to market Somatostatin

2005.06.15

Complete patients recruitment for Cervicitis

2005.06.08

Completion of the Clinical Study of Eye-gel

2005.05.09

Market Isosorbide Mononitrate in HK and China

2005.03.29

Progress in Clinical Study of Eye-gel

2005.03.16

Good progress in Clinical Study in Cervicitis

2005.02.04